Search Results

Showing results 31-41 of 83 for 'Cancer treatment'


  • moshe-oren-tn
    The Moross Integrated Cancer Center at the Weizmann Institute of Science

    Seeing a clear need for a fresh approach to cancer research, the Weizmann Institute established the Moross Integrated Cancer Center (MICC). By collaborating with researchers and physicians; focusing on prevention, diagnosis, and treatment; and working to move therapies from the lab to the clinic, the MICC is a powerful new weapon in the war on cancer.

    /news-media/feature-stories/the-moross-integrated-cancer-center-at-the-weizmann-institute-of-science
  • Mens-health-month-Fruit-sstock_80152498-thumb
    June is Men's Health Month

    Anchored by a Congressional program, Men's Health Month aims to heighten awareness of preventable health problems and encourage early detection and treatment. The Weizmann Institute is benefitting men's health in ways ranging from timely cancer diagnosis to to new insights into emotional behavior.

    /news-media/feature-stories/june-is-mens-health-month
  • 2015-01-acwis-enews-header-thumbnailcfb087dac497647cb66dff00005fc039
    Looking Back, Looking Forward

    Please take a moment to revisit the Weizmann Institute's noteworthy research from 2014, and stay tuned in 2015 for still more amazing breakthroughs. We're looking forward to blowing your mind, changing your life, saving the world – or just making you stop, think, and wonder.

    /news-media/feature-stories/looking-back-looking-forward
  • weizmann-views-moshe-oren-tn
    Using Basic Science to Advance Cancer Research

    Prof. Moshe Oren has spent decades studying the p53 gene, which plays a key role in keeping healthy cells from turning cancerous. His basic research has inspired other scientists to build on his findings, potentially leading to p53-based cancer treatments. As head of the Moross Integrated Cancer Center, Prof. Oren's knowledge will be more valuable than ever.

    /news-media/feature-stories/using-basic-science-to-advance-cancer-research
  • stop-prostate-cancer-tn
    Revolutionary Therapy for Prostate Cancer Coming to Europe

    Tookad, the prostate cancer treatment developed by Profs. Avigdor Scherz and Yoram Salomon, ""now is undergoing advanced trials in Israel and Europe,"" says Israel21c. Already approved for use in Mexico and on the verge of being more widely available, Tookad's efficacy for other cancers is now being tested in collaboration with Oxford University and Memorial Sloan Kettering.

    /news-media/in-the-news/revolutionary-therapy-for-prostate-cancer-coming-to-europe
  • preventing-cancer-tn
    Preventing Cancer: The Weizmann Institute's Moross Integrated Cancer Center

    The Weizmann Institute of Science's Moross Integrated Cancer Center (MICC) aims to revolutionize cancer prevention, detection, and treatments. Several of the senior scientists involved with the MICC – Prof. Zvi Livneh, Prof. Moshe Oren, Dr. Tamar Paz-Elizur, Dr. Eran Elinav, and Dr. Ayelet Erez – discuss directions in cancer prevention research.

    /news-media/video-gallery/preventing-cancer-the-weizmann-institutes-moross-integrated-cancer-center
  • 2017-10-ACWIS-Enews.jpg
    October is National Breast Cancer Awareness Month. How is Weizmann Helping?

    October is National Breast Cancer Awareness Month, and people everywhere are running, walking, and even shopping in support – and, at the Weizmann Institute of Science, investigating, researching, and pursuing creative new ways to attack this still-insidious, too-common disease. Our devoted scientists are developing ways to detect breast cancer early, designing more effective treatments, and better preventing it in the first place. Learn what Weizmann is doing about breast cancer – and how you can help.

    /news-media/feature-stories/october-is-national-breast-cancer-awareness-month
  • header-thumbnail
    Immunotherapy: Cancer Treatment Based on Weizmann Research is Saving Lives

    Weizmann Institute basic research is, yet again, behind the headlines: a new blood cancer therapy that uses one's own immune system to defeat the disease is stunning clinicians and giving patients hope. Trials in the U.S. have had amazing results, with critically ill leukemia patients now in remission. The breakthrough is based on decades of research by Weizmann's Prof. Zelig Eshhar, who is now working to adapt his method to other forms of cancer.

    /news-media/feature-stories/immunotherapy-cancer-treatment-based-on-weizmann-research-is-saving-lives